Follow

Life Sciences Notes Blog

Herbert Smith Freehills Kramer LLP

Articles: 1-10 of 12

Venture investment in life sciences - Activity update & outlook (US & Europe)

European Union, USA - October 15 2025 Life sciences venture activity levels remained stable in 2024 and total investment value in the sector was up after a two-year period of decline. So…

Biopharma M&A activity - as we enter the latter months of 2025, strategics continue to lead the way

United Kingdom - September 24 2025 As we entered 2025, we were hopeful for a more upbeat year for pharma M&A activity but, with headwinds still swirling, a dramatic change of pace…

The Thursday Investment Club: The case for later living

United Kingdom - August 28 2025 With the UK's ageing population projected to increase, the market for later living homes continues to evolve and, with its potential for growth…

Pharma remains an enforcement focus in China - SAMR orders unwinding of a completed pharma deal

China - August 18 2025 Recent years have seen regulator focus on the pharmaceutical sector in China intensify and enforcement has become a key priority. A recent decision…

Sustainability - trends and developments life sciences companies should be aware of

European Union, United Kingdom - November 19 2024 No longer peripheral to how businesses operate, sustainability has cemented itself as a cornerstone of corporate risk management and the…

The new UK Regulatory Innovation Office - a step in the right direction for UK life sciences

United Kingdom - October 11 2024 The UK Government has announced the launch of the new Regulatory Innovation Office (Rio) which is aimed at reducing regulatory burden and speeding up…

H1 2024 - a steady start for biopharma M&A

United Kingdom - August 15 2024 Following a wave of sizeable biopharma transactions announced in the final quarter of 2023, we came into 2024 with optimism that deal making in the…

A new Labour Government - what might this mean for the UK life sciences industry?

United Kingdom - August 7 2024 Published in February 2024, Labour's pre-election life sciences strategy, "A prescription for growth" (the Strategy) provided an early insight into…

UPC finds Edwards' patent valid (as amended) - Meril's revocations dismissed

European Union, United Kingdom - July 23 2024 The Paris Central Division court of the UPC has found Edwards Lifesciences Corporation's heart valve patent valid (as amended by conditional…

Biotech in the crosshairs of global politics - the draft US Biosecure Act

USA - June 28 2024 Less than two years after the Inflation Reduction Act, another piece of US legislation with global impact is on the minds of the pharma and biotech…

About Life Sciences Notes

Welcome to Life Sciences notes – a know-how and news blog where you will find analysis of the latest legal developments relevant to the life sciences.

You can use the drop-down arrows at the top of the site to select material based on category, type of post, or year. Alternatively, enter a term in the search box at the top right-hand corner if you want to find all articles containing the term in question.

You can subscribe to this site if you would like our updates sent to you by e-mail as soon as they are posted – see the yellow subscribe box.

Please note that each blog post published on this site is current as at the date of publication shown. Posts are not amended or updated to reflect subsequent developments.

Featured authors